Zacks Investment Research
13 Jul 2026, 17:46 UTC · 5h ago
Looking for a Growth Stock? 3 Reasons Why Cardinal (CAH) is a Solid Choice
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
13 Jul 2026, 17:46 UTC · 5h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Cardinal Health (CAH) is projected to have earnings per share (EPS) growth of 11.5% this year, exceeding the industry average of 7.5%. — Outperforming industry earnings growth is a primary driver for stock price appreciation in growth-oriented equities.
+0.40Cardinal Health reports a sales-to-total-assets (S/TA) ratio of 4.49, significantly higher than the industry average of 0.7. — Superior asset utilization suggests higher operational efficiency compared to peers, which supports a bullish valuation.
+0.30Which stocks this story touches
Zacks recommends the stock as a 'Strong Buy' based on its top Growth Style Score, strong projected earnings growth, and efficient asset utilization.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
5h ago
